22 May 2013
Keywords: gsk, initiates, trial, cervarix, vs, merck, gardasil
Article | 22 January 2007
UK drug major GlaxoSmithKline has initiated a head-to-head trial of its cervical cancer vaccine Cervarix versus Merck & Co's competitor
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 January 2007
21 May 2013
© 2013 thepharmaletter.com